More on LRMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+41.0% Growth)
- Ratings (9.2 Score)

Upcoming Events

- Earnings (11/5/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Larimar Therapeutics (NQ:LRMR)
Delayed: 3.94 +0.12 (3.14%)
Prev. Close $3.82  
Open$3.78 
52 Wk High$ 
52 Wk Low$ 
Day High$3.95 
Day Low$3.77 
P/E N/A  
EPS$ 
Volume755,350 

Friends, Peers and Foes (?): KBLB, META, MVRS, VIR, GSGN (more...)

Aug 4, 2026 07:24 AM Larimar Therapeutics, Inc. (LRMR) Tops Q2 EPS by 8c
Aug 4, 2026 07:12 AM Form 10-Q Larimar Therapeutics, For: Jun 30
Aug 4, 2026 07:03 AM Form 8-K Larimar Therapeutics, For: Aug 04
Aug 4, 2026 07:00 AM Larimar Therapeutics Reports Second Quarter 2026 Financial and Business Update
Jul 8, 2026 04:05 PM Form 4 Larimar Therapeutics, For: Jul 06 Filed by: Hamilton Thomas Edward
Jul 7, 2026 05:21 AM Larimar Therapeutics (LRMR) Reiterated at Market Outperform by Citizens
Jul 2, 2026 06:05 AM H.C. Wainwright Assumes Larimar Therapeutics (LRMR) at Buy
Jun 30, 2026 06:54 AM Larimar Therapeutics (LRMR) PT Lowered to $5 at Baird
Jun 29, 2026 06:34 AM Form 8-K Larimar Therapeutics, For: Jun 29
Jun 29, 2026 06:30 AM Larimar files first BLA module for Friedreich's ataxia drug
View All Articles

Entities mentioned with LRMR

View All Entities